
Conference Coverage
Latest Content

Centanafadine Pharmacological Profile Affirms Potential for Treatment of ADHD

First Patient Dose in Phase 3 Trial of AXS-14 for Treatment of Fibromyalgia

A Network-Based Approach to Depression, Neuropathic Pain, and Substance Use Disorder Using Coadministered TMS and Ketamine

I Wanted to Die. Now, I Help Others Choose Life.

New Head-to-Head Data Shows Higher VMAT2 Target Occupancy for Ingrezza Compared With Austedo XR

Shorts










Digital Edition
Podcasts
All News

Psychiatrists explore the mental health impacts of protests, emphasizing the need for community support and ethical responsibility in turbulent times.

Explore groundbreaking insights from the 2025 Southern Florida Psychiatry Conference, covering VNS for depression, stuttering management, and postpartum care.

Explore the transformative impact of artificial intelligence on modern life, from health care advancements to productivity enhancements and ethical considerations.

Scienture's Rezenopy, the highest-dose naloxone nasal spray approved by the FDA, gains patent protection.

A look at upcoming presentations at APSARD 2026, January 15-18.

FDA removes suicidal ideation warnings from GLP-1 RA medications, highlighting their potential benefits in weight loss and mental health treatment.

"I’m idling on the parking garage roof..."

Exploring the complex legacy of Oliver Sacks, this article examines the blurred lines between truth and fiction in his case studies.

Experts discuss the rapid evolution of chatbots, their impact on humanity, and the future of psychotherapy in a transformative technological era.

Cassava Sciences shares insights from phase 3 trials of simufilam for Alzheimer disease, revealing potential treatment differences despite unmet primary endpoints.

FDA approves ProlivRx, a groundbreaking at-home therapy for major depressive disorder, offering new hope for patients unresponsive to traditional treatments.

Explore the unique mood-stabilizing properties of antiepileptics like lamotrigine, valproic acid, and carbamazepine in bipolar disorder treatment.

Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.

Explore the complex relationship between gender, sexual health, and mental health with insights from expert Eugene T. Lucas Jr, DNP, CRNP, FNP-BC, APMHNP-BC.

Explore the diverse legacies of influential psychiatrists who shaped mental health, from poetry to cooking, highlighting their profound impact on society.








































